Enterprise Financial Services Corp (EFSC)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,048
Closed -$334K 476
2021
Q3
$334K Buy
3,048
+2,978
+4,254% +$309K 0.04% 230
2021
Q2
$7K Buy
70
+28
+67% +$2.58K ﹤0.01% 869
2021
Q1
$4K Buy
42
+31
+282% +$2.62K ﹤0.01% 1027
2020
Q4
$1K Buy
+11
New +$818 ﹤0.01% 1291
2020
Q2
Sell
-29
Closed -$1K 1402
2020
Q1
$1K Buy
+29
New +$981 ﹤0.01% 1265
2017
Q1
Sell
-116
Closed -$2K 1119
2016
Q4
$2K Hold
116
﹤0.01% 965
2016
Q3
$2K Buy
+116
New +$2.27K ﹤0.01% 918
2016
Q2
Sell
-48
Closed -$1K 1077
2016
Q1
$1K Sell
48
-123
-72% -$2.15K ﹤0.01% 1023
2015
Q4
$4K Buy
+171
New +$3.33K ﹤0.01% 799
2015
Q3
Sell
-51
Closed -$2K 1174
2015
Q2
$2K Buy
+51
New +$1.56K ﹤0.01% 953

Other funds holding HZNP

Enterprise Financial Services Corp (EFSC)'s HZNP Position: Q4 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2021, closing a stake of 3,048 shares — an estimated $334K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in HZNP in Q2 2015 and held it in 10 quarters. The position peaked at $334K in Q3 2021. 611 funds tracked by Wall St. Rank hold HZNP as of Q4 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 3,048 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2021, an estimated $334K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 10 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $334K in Q3 2021.
  • 611 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2021, filed 14 Feb 2022.